Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Open-label Trial-

NCT01398410 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT01398410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01398410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Open-label Trial-
Lead sponsor
Eisai Co., Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2011
Completion date
February 28, 2014
Enrollment
405 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

gastric ulcers duodenal ulcers caused by low-dose aspirin